Registry for patients with coronary artery disease and atrial fibrillation
NEXUS Registry: An Outcomes Database Which Tracks Patient -Reported Outcomes After Percutaneous Coronary Intervention for Coronary Artery Disease Along With Surgical and Subcutaneous Ablation for the Management of Atrial Fibrillation.
This study collects information from patients with coronary artery disease and atrial fibrillation to see how local care can improve their symptoms and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cardiovascular Innovation and Research Institute Academic / other |
| Locations | 1 site (Glenwood Springs, Colorado) |
| Trial ID | NCT03428048 on ClinicalTrials.gov |
What this trial studies
This observational study collects data from patients with coronary artery disease and atrial fibrillation through disease-specific questionnaires, which are then combined with information from the National Cardiovascular Data Registry. The aim is to analyze this data continuously to improve the quality of care at a low-volume institution for procedures like percutaneous coronary intervention and endocardial ablation. By focusing on patient-reported outcomes and clinical effectiveness, the study seeks to demonstrate that quality care can be provided close to home, enhancing patient symptoms and overall quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old diagnosed with coronary artery disease or atrial fibrillation who can provide informed consent.
Not a fit: Patients who are unable or unwilling to provide informed consent or have issues maintaining follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient outcomes and access to quality cardiovascular care in low-volume centers.
How similar studies have performed: Other studies have shown success with similar registry approaches in improving quality of care and patient outcomes, indicating this method is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Candidates will be included in the study only if all the following conditions are met: 1. Age \>18 years 2. The subject has been informed of the nature of the study, agrees to its provisions, is able to comprehend, and has provided informed consent. 3. The subject is available for follow-up. 4. The subject has a diagnosis of coronary artery disease or Afib. Exclusion Criteria: Candidates will be excluded from the study if any of the following conditions are present: 1. Failure and / or inability and / or unwillingness to provide informed consent. 2. Likely problems, in the judgement of the investigators, with maintaining follow-up.
Where this trial is running
Glenwood Springs, Colorado
- Valley View Hospital — Glenwood Springs, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Frank A Laws, MD — Valley View Hospital
- Study coordinator: Kim M Williams, MPH
- Email: kim.williams@vvh.org
- Phone: 970-384-7433
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.